Skip to main content
. 2021 Mar 31;129(3):037010. doi: 10.1289/EHP8222

Figure 1.

Figure 1A and 1B(1) are representative images of chloroacetate esterase stain stained liver section and picrosirius stained liver sections in mice with 50 micrometers captured by 200 X objective lens plotting saline and epidermal growth factor (0.2 microgram per gram) columns across corn oil and aroclor 1260 (20 milligrams per kilogram) rows, respectively. Figure 1B2 is a box plot graph plotting Percentage Area Sirius Red Staining, ranging from 0 to 8 in increments of 2 (y-axis) across control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor (x-axis). Figure 1C1, 1C2, and 1C3 are box plot graphs plotting tumor necrosis factor lowercase alpha (picogram per milliliter), ranging from 0 to 15 in increments of 5; Plasminogen activator inhibitor-1 (picogram per milliliter), ranging from 0 to 8000 in increments of 2000; and Resistin (picogram per milliliter), ranging from 0 to 5000 in increments of 1000 (y-axis) across control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor (x-axis), respectively. Figure 1D and 1E are clustered box plot graphs plotting Fold-Change, ranging from 0 to 10 in increments of 5 and 0.0 to 2.5 in increments of 0.5 (y-axis) across tumor necrosis factor lowercase alpha, interleukin 6, Lymphocyte Antigen 6 Family Member G 6 D, and Cluster of Differentiation 68, each includes control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor, and Transforming Growth Factor Beta 1 and Myocyte-specific enhancer factor 2C, each includes control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor (x-axis).

Measures of hepatic inflammation and fibrosis in mice fed an HFD±Aroclor 1260 exposure±EGF treatment: Male WT C57Bl/6 mice were fed an HFD (12 wk) and exposed to either vehicle or Aroclor 1260 (20mg/kg) by a one-time oral gavage at week 1. Aroclor 1260-exposed or vehicle mice were treated (via IP injection) with saline or EGF (0.2μg/g) daily for 10 d starting at week 10. Mice were fasted for 12 h and euthanized, and tissues were harvested for downstream analyses. (A) Representative image of CAE stained liver section (n=17 per group, 1 liver section per mouse evaluated) (20× magnification objective) (arrows denote necrotic foci). (Bi) Representative image of picrosirius red stained (10× magnification objective) liver sections and (Bii) quantification. One liver section per mouse was evaluated (n=17 per experimental group). (C) Plasma measures by Luminex® of TNFα, PAI-1, and resistin. (D) Hepatic qPCR analysis of inflammatory gene marker expression (Tnfα, Il-6, Ly6g6d, Cd68, Tlr4). (E) Hepatic qPCR analysis of profibrotic genes Tgfβ and Mef2c, and an n=17 was used for Figures 1B–F. A two-way ANOVA was used to statistically compare data sets followed by a Sidak correction for intergroup comparisons. A p<0.05 was considered significant. Significance due to EGF is denoted by (a), due to Aroclor 1260 denoted by (b), and due to interaction denoted by (c) for the two-way ANOVA. A p<0.05 was denoted by * for the Sidak multiple comparison test. Data are presented as box and whisker plots for Figure 1 that illustrate the median (midline), upper and lower quartiles (box), and the upper and lower limits (whiskers). All numerical data are presented in Table S6 “Numerical Data” as mean±SD, and p-values can be found in Table S5 “p-Values.” Numeric outliers were identified by ROUT method and removed. The number of outliers are reported in Table S4 “Outliers.” Note: AE, Aroclor 1260+EGF; ANOVA, analysis of variance; AS, Aroclor 1260+saline; CAE, chloroacetate esterase; Cd68, cluster of differentiation 68; CE, control+EGF; CS, control+saline; EGF, epidermal growth factor; HFD, high-fat diet; Il-6, interleukin-6; IP, intraperitoneal; Ly6g6d, lymphocyte antigen 6 family member G6D; Mef2c, myocyte enhancer factor 2C; qPCR, quantitative real-time polymerase chain reaction; Tgfb, Transforming growth factor-beta; Tlr4, toll-like receptor 4; TNFα, tumor necrosis factor-alpha.